Treatment of breast cancer patients by neoadjuvant systemic therapy has traditionally been used to treat locally advanced inoperable and inflammatory cancers or preceding breast conserving surgery [1]. A recent pooled analysis from the Collaborative Trials in Neoadjuvant Breast Cancer (CTNeoBC) international working group demonstrated that pathologic complete responses (pCR) are correlated with better long term outcomes (event free survival and overall survival [OS]). This was particularly true for the more aggressive breast cancer subtypes (i.e.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2qqftyz
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Pulmonary complications post hematopoietic stem cell transplant in dyskeratosis congenita: analysis of oxidative stress in lung fibrobl...
-
Masters Thesis Proposal Outline INTRODUCTION (1 PAGE) • What is the general topic area • Why this topic is relevant/important (how important...
-
Be a Responsible Dog Owner . Among companion animals, dogs are unmatched in their devotion, loyalty and friendship to humankind. Anyone who ...
-
Nothing is impossible, the word itself says 'I'm possible'! - Audrey Hepburn quotes from from #AlexandrosSfakianakis via Alexa...
-
Publication date: Available online 5 April 2017 Source: European Annals of Otorhinolaryngology, Head and Neck Diseases Author(s): C.A. Ri...
-
Abstract We present a case of small coronary sinus defect detected after transcatheter device closure of a large secundum atrial septal de...
-
Background. Antitumor necrosis factor (anti-TNF) therapy is a highly effective but costly treatment for inflammatory bowel disease (IBD). Me...
-
The Unusual Presentation of a Myxoma within the Sphenoid Sinus: Case Report and Review of the Literature. World Neurosurg. 2017 Apr 19...
-
Abstract Purpose of Review Recent evidence suggests that the developmental signaling pathways—Wnt, Notch, and Hedgehog—are critically in...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου